AvePoint, Inc. (AVPT) Market Cap & Valuation Ratios
AvePoint, Inc. (AVPT) has a market cap of $3.5B, a trailing P/E of 51.6 and a price-to-sales ratio of 7.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AVPTAvePoint, Inc.Follow AVPT — free
—
Price chart with a free account
- Market cap
- 3.5B
- P/E TTM
- 51.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
software - infrastructure · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| AVPT | 3.5 | 51.6 | 6.6 | 59.1 | 2.8% | +25% | 10% | 240% |
| DLO | 4.4 | 22.1 | 2.7 | 13.7 | 9.6% | +57% | 17% | — |
| BLSH | 4.3 | — | 0.0 | — | 0.4% | -2% | -0.3% | -24% |
| CORZ | 4.2 | — | 15.3 | — | — | +26% | -127% | -515% |
| PAY | 4.2 | 50.5 | 2.8 | 26.9 | 2.9% | +30% | 8% | 32% |
| APPN | 3.8 | — | 4.8 | 194.7 | 2.0% | +21% | 1% | 18% |
| STNE | 3.6 | — | — | — | — | +17% | 20% | 9% |
| TDC | 3.2 | — | 1.7 | 12.7 | 22.6% | +1.0% | 8% | 43% |
| FOUR | 3.1 | 62.6 | 1.5 | 7.8 | 10.2% | +32% | 8% | 8% |
| NTCT | 2.9 | 24.3 | 2.6 | 12.0 | 8.9% | +6% | 15% | 10% |
| FIVN | 2.8 | 54.5 | 2.4 | 22.8 | 6.1% | +9% | 5% | 4% |
| Median of these 10 | 50.5 | 2.6 | 13.7 | 7.5% | +19% | 8% | 9% |
P/E 51.6 vs. a peer median of 50.5; EV/Sales 6.6 vs. 2.6.
Growth vs. price
each dot a company · hover or tap for valuesBLSH and CORZ and APPN and STNE and TDC have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
AvePoint, Inc. — questions
- What is AvePoint, Inc.'s market cap?
- $3.5B.
- What is AvePoint, Inc.'s P/E ratio?
- 51.6 on trailing twelve-month earnings to 2026-06-30.
- What is AvePoint, Inc.'s price-to-sales ratio?
- 7.5.
Every figure on this page comes from AvePoint, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.